Drug delivery’s double threat, enabled by collaboration
Drug delivery technology advances are improving and preserving the health of millions of people around the world.
This issue of Medical Design & Outsourcing dives deep into drug delivery, with features focused on drug delivery’s dual abilities of disease prevention and health restoration, coverage of two key materials — adhesives and silicone — plus drug delivery design tips and regulatory expertise.
Our cover story explores next-generation inhalable vaccines and the nebulizer technology used to deliver them deep into the lungs. These drugs and delivery technologies show promising potential for more effective, more affordable and more accessible vaccinations for deadly respiratory diseases like influenza and COVID-19 — but they won’t make it to to patients without collaboration, warns Aerogen Director of R&D, Science and Emerging Technologies Ronan MacLoughlin. (Special thanks to Artery Studios for this month’s cover illustration.)
We examine drug delivery’s restorative impact in our feature on type 2 diabetes technology, where automation, miniaturization, real-time information and device developer partnerships are making it easier for patients to treat their chronic condition.
This issue also includes coverage of technologies beyond drug delivery, including a feature on Medtronic’s development of adaptive deep brain stimulation therapy and lessons from the project shared by Senior Distinguished Engineer Scott Stanslaski.
In our Nitinol department, we take a first look at Boston Scientific’s investigational Faraflex pulsed field ablation (PFA) and mapping catheter with Dr. Brad Sutton, the chief medical officer of Boston Scientific’s Atrial Solutions Business.
In our Tubing department, we interview Shockwave Medical Chief Medical Officer Dr. Nick West to learn more about how the new Javelin intravascular lithotripsy catheter — recently launched by parent company Johnson & Johnson MedTech — breaks up calcium in some of the most challenging clogged blood vessels.
And ahead of their presentation at DeviceTalks Boston April 30-May 1, two lawyers offer advice for medical device startups on M&A and intellectual property in today’s tumultuous market.
I’d also like to thank the entire Medical Design & Outsourcing team for their work, which has once again been honored as a national finalist for overall excellence in business-to-business media by the American Society of Business Publication Editors (ASBPE).
This recognition wouldn’t be possible without the support of our readers, our advertisers, and the medtech insiders who graciously lend us their time and expertise to advance the medtech mission. We’re fortunate to have the opportunity to enable collaboration and innovation in the medical device industry, and we strive to consistently exceed your expectations in new and surprising ways.
As always, I hope you enjoy this edition of Medical Design & Outsourcing — and thanks for reading.
– Jim Hammerand, Managing Editor
Medical Design & Outsourcing
[email protected]
